DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Claritin (Loratadine) - Reports of Side Effects & Adverse Reactions

 



This is an index of reports of adverse events (side effects, adverse reactions, etc.) related to Claritin (Loratadine). Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the side effect / adverse reaction. Or scroll down to view a sample of recent reports further on this page.

Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.

All cases (99)
     Dyspnoea (10)Loss of Consciousness (10)Malaise (10)more >>

Cases resulting in a serious event (97)
     Dyspnoea (10)Loss of Consciousness (10)Malaise (10)more >>

Cases resulting in death (1)
     Electrocardiogram QT Prolonged (1)Loss of Consciousness (1)Ventricular Fibrillation (1)

Cases resulting in life threatening events (1)
     Dementia (1)Anorexia (1)Ventricular Tachycardia (1)more >>

Cases resulting in hospitalization (19)
     Malaise (4)Fall (3)Blood Alkaline Phosphatase Increased (2)more >>

Cases resulting in other serious reactions (83)
     LIP Swelling (9)Dyspnoea (9)Loss of Consciousness (9)more >>

Below is a sample of reports where side effects / adverse reactions may be related to Claritin (Loratadine). For a complete list and/or a specific selection of reports, please use the links in the index above.

Adverse event in 50 year old male receiving Claritin (Loratadine)

Reported by a physician from Japan on 2007-10-29

Patient: 50 year old male

Adverse reactions / side effects: Malaise, Nausea, Hypotension, Dizziness, Cold Sweat, Asthenia

Suspect drug(s):
Claritin (Loratadine)



Adverse event in 4 year old female receiving Claritin (Loratadine)

Reported by a consumer/non-health professional from Brazil on 2007-10-29

Patient: 4 year old female, weighing 18.0 kg (39.6 pounds)

Adverse reactions / side effects: Acute Sinusitis, Hypothermia

Adverse event resulted in: hospitalization

Suspect drug(s):
Claritin
    Dosage: 2.5 ml; qd; po
    Administration route: Oral
    Indication: Hypersensitivity
    Start date: 2007-10-07
    End date: 2007-10-14

Novalgina (Metamizole Sodium)
    Dosage: ; qid; po
    Administration route: Oral
    Indication: Sinusitis



Adverse event in 48 year old male receiving Claritin (Loratadine)

Reported by a consumer/non-health professional from United States on 2007-10-18

Patient: 48 year old male, weighing 122.5 kg (269.4 pounds)

Adverse reactions / side effects: Hypertension

Suspect drug(s):
Claritin
    Dosage: po
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication
    Start date: 2007-10-01

Claritin-D 24 Hour
    Dosage: 1 df; qd; po
    Administration route: Oral
    Indication: Nasopharyngitis
    Start date: 2007-09-01
    End date: 2007-10-02

Other drugs received by patient: Advair (Con.); Flonase (Con.)



Adverse event in 97 year old male receiving Claritin (Loratadine)

Reported by a consumer/non-health professional from United States on 2007-10-11

Patient: 97 year old male, weighing 64.9 kg (142.7 pounds)

Adverse reactions / side effects: Malaise, Chest Discomfort, Angina Pectoris

Suspect drug(s):
Claritin (Loratadine)

Other drugs received by patient: Plavix; Lipitor; Toprol-XL



Adverse event in receiving Claritin (Loratadine)

Reported by a consumer/non-health professional from United States on 2007-10-11

Patient:

Adverse reactions / side effects: Pharyngeal Oedema

Suspect drug(s):
Claritin
    Dosage: po
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication

Singulair
    Indication: Drug USE FOR Unknown Indication



Adverse event in receiving Claritin (Loratadine)

Reported by a consumer/non-health professional from United States on 2007-10-10

Patient:

Adverse reactions / side effects: Pharyngeal Oedema

Suspect drug(s):
Claritin
    Administration route: Oral

Singulair
    Administration route: Oral



Adverse event in 28 year old male receiving Claritin (Loratadine)

Reported by a physician from Japan on 2007-10-10

Patient: 28 year old male, weighing 58.0 kg (127.6 pounds)

Adverse reactions / side effects: Dermatitis Atopic, Generalised Erythema, Joint Swelling, Ocular Hyperaemia, Condition Aggravated, Upper Respiratory Tract Inflammation, Erythema Multiforme

Adverse event resulted in: hospitalization

Suspect drug(s):
Bufferin A (Bufferin A)
    Dosage: 1 df; ; po
    Administration route: Oral
    Indication: Headache
    End date: 2007-07-28

Claritin
    Dosage: 10 mg; ; po
    Administration route: Oral
    Indication: Pruritus
    End date: 2007-07-29

EVE Quick (NO Pref. Name)
    Dosage: 1 df; ; po
    Administration route: Oral
    Indication: Headache

Tavegyl (NO Pref. Name)
    Dosage: 1 df; ; po
    Indication: Pruritus



Adverse event in receiving Claritin (Loratadine)

Reported by a consumer/non-health professional from United States on 2007-10-01

Patient:

Adverse reactions / side effects: Pharyngeal Oedema

Suspect drug(s):
Claritin (Loratadine)



Adverse event in female receiving Claritin (Loratadine)

Reported by a consumer/non-health professional from United States on 2007-07-23

Patient: female

Adverse reactions / side effects: Pharyngeal Oedema, Face Oedema, Eye Oedema, Headache

Suspect drug(s):
Claritin (Loratadine)



Adverse event in 65 year old female receiving Claritin (Loratadine)

Reported by a consumer/non-health professional from United States on 2007-07-23

Patient: 65 year old female, weighing 64.0 kg (140.7 pounds)

Adverse reactions / side effects: Confusional State, Hypersensitivity, Pruritus, Urticaria, Loss of Consciousness, Burning Sensation, Road Traffic Accident, Fatigue, Rash Erythematous, Pharmaceutical Product Complaint, Blister

Suspect drug(s):
Ambien CR
    Indication: Insomnia
    Start date: 2001-01-01

Claritin
    Dosage: 1 df;qd;po
    Administration route: Oral
    Indication: Lacrimation Increased
    Start date: 2007-05-14
    End date: 2007-05-17

Claritin
    Dosage: 1 df;qd;po
    Administration route: Oral
    Indication: Rhinorrhoea
    Start date: 2007-05-14
    End date: 2007-05-17

Detrol LA
    Indication: Hypertonic Bladder
    Start date: 2002-01-01

Lipitor
    Dosage: 10 mg;
    Indication: Blood Cholesterol Increased
    Start date: 2004-01-01

Wellbutrin
    Indication: Depression
    Start date: 2001-01-01

Other drugs received by patient: Estrogen NOS



Adverse event in receiving Claritin (Loratadine)

Reported by a consumer/non-health professional from United States on 2007-07-20

Patient:

Adverse reactions / side effects: Pharyngeal Oedema

Suspect drug(s):
Claritin (Loratadine)



Adverse event in 61 year old male receiving Claritin (Loratadine)

Reported by a physician from Japan on 2007-07-20

Patient: 61 year old male

Adverse reactions / side effects: Impaired Driving Ability, Drug Effect Decreased, Road Traffic Accident, Somnolence

Suspect drug(s):
Claritin
    Dosage: see image
    Administration route: Oral
    Indication: Urticaria
    Start date: 2007-03-10
    End date: 2007-06-25

Claritin
    Dosage: see image
    Administration route: Oral
    Indication: Urticaria
    Start date: 2007-06-26
    End date: 2007-07-04

Other drugs received by patient: Zantac 150; Atarax



Adverse event in 69 year old male receiving Claritin (Loratadine)

Reported by a consumer/non-health professional from United States on 2007-07-18

Patient: 69 year old male

Adverse reactions / side effects: Blood Glucose Decreased

Suspect drug(s):
Avandryl
    Dosage: ;po
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication

Claritin
    Dosage: ;po
    Administration route: Oral
    Indication: Lacrimation Increased
    Start date: 2007-06-30
    End date: 2007-07-01

Claritin
    Dosage: ;po
    Administration route: Oral
    Indication: Sneezing
    Start date: 2007-06-30
    End date: 2007-07-01

Claritin
    Dosage: ;po
    Administration route: Oral
    Indication: Throat Irritation
    Start date: 2007-06-30
    End date: 2007-07-01

Insulin
    Indication: Drug USE FOR Unknown Indication

Other drugs received by patient: Tarka; Hydrochlorothiazide; Lipitor; Indomethacin; Metoprolol Succinate



Adverse event in 6 year old male receiving Claritin (Loratadine)

Reported by a consumer/non-health professional from United States on 2007-07-18

Patient: 6 year old male, weighing 20.4 kg (44.9 pounds)

Adverse reactions / side effects: Abnormal Behaviour, Aggression

Suspect drug(s):
Claritin (Loratadine)



Adverse event in 91 year old female receiving Claritin (Loratadine)

Reported by a physician from Japan on 2007-07-18

Patient: 91 year old female, weighing 44.1 kg (97.0 pounds)

Adverse reactions / side effects: Ventricular Tachycardia, Anorexia, Dementia, Cardiac Failure Congestive

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Claritin
    Dosage: 10 mg; ; po
    Administration route: Oral
    Indication: Impetigo
    Start date: 2007-04-30
    End date: 2007-05-18

Claritin
    Dosage: 10 mg; ; po
    Administration route: Oral
    Indication: Pruritus
    Start date: 2007-04-30
    End date: 2007-05-18

Minocycline HCL
    Dosage: 100 mg;qd;po
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication
    Start date: 2007-05-02
    End date: 2007-05-16

Other drugs received by patient: Gentacin; Rinderon



Adverse event in 62 year old female receiving Claritin (Loratadine)

Reported by a consumer/non-health professional from Canada on 2007-07-16

Patient: 62 year old female

Adverse reactions / side effects: Myalgia, Chest Pain, Throat Tightness

Suspect drug(s):
Claritin (Loratadine)



Adverse event in 63 year old female receiving Claritin (Loratadine)

Reported by a consumer/non-health professional from United States on 2007-07-11

Patient: 63 year old female, weighing 77.1 kg (169.6 pounds)

Adverse reactions / side effects: Glaucoma, Mydriasis, Conjunctivitis, Retinal Disorder

Suspect drug(s):
Claritin
    Dosage: 1 df; qd; po
    Administration route: Oral
    Indication: Hypersensitivity
    Start date: 2005-01-01
    End date: 2007-06-17

Claritin
    Dosage: 1 df; qd; po
    Administration route: Oral
    Indication: Lacrimation Increased
    Start date: 2005-01-01
    End date: 2007-06-17

Claritin
    Dosage: 1 df; qd; po
    Administration route: Oral
    Indication: Sneezing
    Start date: 2005-01-01
    End date: 2007-06-17

Claritin
    Dosage: po
    Administration route: Oral
    Indication: Lacrimation Increased
    End date: 2007-06-15

Claritin
    Dosage: po
    Administration route: Oral
    Indication: Sneezing
    End date: 2007-06-15

Sudafed 12 Hour
    Dosage: po
    Administration route: Oral
    Indication: Lacrimation Increased

Sudafed 12 Hour
    Dosage: po
    Administration route: Oral
    Indication: Sneezing

Other drugs received by patient: Glaucoma Medication



Adverse event in 90 year old receiving Claritin (Loratadine)

Reported by a physician from Japan on 2007-07-11

Patient: 90 year old

Adverse reactions / side effects: Ventricular Arrhythmia

Adverse event resulted in: hospitalization

Suspect drug(s):
Claritin (Loratadine)

Other drugs received by patient: Minomycin (Con.)



Adverse event in male receiving Claritin (Loratadine)

Reported by a health professional (non-physician/pharmacist) from Poland on 2007-07-11

Patient: male

Adverse reactions / side effects: Dyspnoea

Suspect drug(s):
Claritin (Loratadine)

Other drugs received by patient: Diphergan / 00033002 / (Con.)



Adverse event in 53 year old female receiving Claritin (Loratadine)

Reported by a consumer/non-health professional from United States on 2007-07-11

Patient: 53 year old female, weighing 63.5 kg (139.7 pounds)

Adverse reactions / side effects: Dyspnoea, Malaise, NO Therapeutic Response, Condition Aggravated, Multiple Allergies, Throat Tightness

Suspect drug(s):
Claritin
    Dosage: 1 df; po
    Administration route: Oral
    Indication: Multiple Allergies
    Start date: 2007-05-01
    End date: 2007-05-01

Claritin
    Dosage: 1 df; po
    Administration route: Oral
    Indication: Rhinorrhoea
    Start date: 2007-05-01
    End date: 2007-05-01

Claritin
    Dosage: 1 df; po
    Administration route: Oral
    Indication: Sneezing
    Start date: 2007-05-01
    End date: 2007-05-01



Adverse event in 63 year old female receiving Claritin (Loratadine)

Reported by a consumer/non-health professional from United States on 2007-07-05

Patient: 63 year old female

Adverse reactions / side effects: Mydriasis, Glaucoma, Conjunctivitis

Suspect drug(s):
Claritin
    Dosage: po
    Administration route: Oral
    Indication: Lacrimation Increased
    End date: 2007-06-15

Claritin
    Dosage: po
    Administration route: Oral
    Indication: Sneezing
    End date: 2007-06-15

Claritin
    Dosage: po
    Administration route: Oral
    Indication: Lacrimation Increased
    End date: 2007-06-15

Claritin
    Dosage: po
    Administration route: Oral
    Indication: Sneezing
    End date: 2007-06-15

Sudafed 12 Hour
    Dosage: po
    Administration route: Oral
    Indication: Lacrimation Increased



Adverse event in 63 year old male receiving Claritin (Loratadine)

Reported by a physician from Japan on 2007-07-05

Patient: 63 year old male

Adverse reactions / side effects: Fistula, Haemorrhoidal Haemorrhage

Suspect drug(s):
Claritin
    Dosage: see image
    Administration route: Oral
    Indication: Eczema
    Start date: 2007-05-09
    End date: 2007-05-11

Claritin
    Dosage: see image
    Administration route: Oral
    Indication: Eczema
    Start date: 2007-05-13
    End date: 2007-05-16



Adverse event in 41 year old female receiving Claritin (Loratadine)

Reported by a consumer/non-health professional from United States on 2007-07-02

Patient: 41 year old female, weighing 45.4 kg (99.8 pounds)

Adverse reactions / side effects: Confusional State, Hypersensitivity, Arthralgia, Dizziness, Metrorrhagia

Suspect drug(s):
Claritin
    Dosage: 1 df; qd; po
    Administration route: Oral
    Indication: Cough
    Start date: 2007-06-07
    End date: 2007-06-08

Claritin
    Dosage: 1 df; qd; po
    Administration route: Oral
    Indication: Hypersensitivity
    Start date: 2007-06-07
    End date: 2007-06-08

Claritin
    Dosage: 1 df; qd; po
    Administration route: Oral
    Indication: Nasal Congestion
    Start date: 2007-06-07
    End date: 2007-06-08



Adverse event in female receiving Claritin (Loratadine)

Reported by a consumer/non-health professional from United States on 2007-06-29

Patient: female

Adverse reactions / side effects: Swelling Face, Pharyngeal Oedema, Eye Swelling, Headache

Suspect drug(s):
Claritin (Loratadine)



Adverse event in 3 year old male receiving Claritin (Loratadine)

Reported by a consumer/non-health professional from United States on 2007-06-29

Patient: 3 year old male, weighing 15.4 kg (33.9 pounds)

Adverse reactions / side effects: Irritability, Aggression

Suspect drug(s):
Claritin
    Dosage: 1 df; qd; po
    Administration route: Oral
    Indication: Hypersensitivity
    Start date: 2007-05-04

Claritin
    Dosage: 1 df; qd; po
    Administration route: Oral
    Indication: Rhinorrhoea
    Start date: 2007-05-04

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009